Recombinant expression of multiprotein complexes using polygenes
Abstract
The present invention relates to a recombinant polynucleotide encoding a polygene coding for at least three polypeptides wherein at least one of the genes constituting the polygene is of non-viral origin, at least two of the polypeptides encoded by the genes constituting the polygene are each capable of at least transiently interacting with at least one other polypeptide encoded by a gene of said polygene, and the genes constituting the polygene are each connected to one another by a sequence coding for at least one protease cleavage site. The present invention also relates to polyproteins encoded by the polygene. Further embodiments of the present invention are a vector containing the recombinant polypeptide, a host cell containing the recombinant polypeptide and/or the vector and a non-human transgenic animal transformed with the recombinant polypeptide and/or the vector. The present invention also relates to methods for the production of the polynucleotide and for the manufacture of multiprotein complexes. The embodiments of the present invention are particularly useful in gene therapy, drug candidate screening, vaccine production and crystallisation of multiprotein complexes for structural investigations.
Claims
exact text as granted — not AI-modified1 - 36 . (canceled)
37 . A polynucleotide encoding at least two polygenes, wherein
each polygene has a single open reading frame (ORF), each polygene comprises at least three genes each coding for a biologically active polypeptide, at least two of the biologically active polypeptides encoded by any genes of the at least two polygenes are of non-viral origin, at least two of the biologically active polypeptides encoded by any genes of the at least two polygenes are each capable of at least transiently interacting with at least one of the other biologically active polypeptides, and the genes constituting each polygene are connected to one another by a sequence coding for at least one self-cleaving peptide, and at least one polygene comprises more than one copy of a gene coding for a biologically active polypeptide.
38 . A transgenic non-human animal transformed with the polynucleotide of claim 37 .
39 . A host cell comprising the polynucleotide of claim 37 .Join the waitlist — get patent alerts
Track US2017037090A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.